Tech Company Financing Transactions
Edgewise Therapeutics Funding Round
Viking Global Investors, Cormorant Asset Management and CureDuchenne Ventures participated in a $95 million Series C funding round for Edgewise Therapeutics. The round closed on 12/10/2020.
Viking Global Investors (Lead Investor)
Deerfield Capital (Robert Jackson)
OrbiMed (Peter Thompson)
U.S. Venture Partners (Jonathan Root)
Boulder, CO 80304
Browse more venture capital transactions:
Prev: 12/10/2020: Squire Technologies venture capital transaction
Next: 12/10/2020: Arthur venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs